These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 12012149)

  • 21. Migraine.
    Edmeads JG
    CMAJ; 1988 Jan; 138(2):107-13. PubMed ID: 2891428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rejection and acceptance of possible side effects of migraine prophylactic drugs.
    Kowacs PA; Piovesan EJ; Tepper SJ
    Headache; 2009 Jul; 49(7):1022-7. PubMed ID: 19438733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ergot Use and Overuse: A Pharmacoepidemiology Retrospective Cohort Study.
    Donnet A; Braunstein D; Pradel V; Sciortino V; Allaria-Lapierre V; Micallef J; Lanteri-Minet M
    Headache; 2016 Mar; 56(3):547-54. PubMed ID: 26995706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prophylactic drug management of migraine].
    Göbel H; Heinze A
    Schmerz; 2002 Jun; 16(3):223-40. PubMed ID: 12077682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Headache treatment before and after the consultation of a specialized centre: a pharmacoepidemiology study.
    Ferrari A; Pasciullo G; Savino G; Cicero AF; Ottani A; Bertolini A; Sternieri E
    Cephalalgia; 2004 May; 24(5):356-62. PubMed ID: 15096224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triptans use and overuse: A pharmacoepidemiology study from the French health insurance system database covering 4.1 million people.
    Braunstein D; Donnet A; Pradel V; Sciortino V; Allaria-Lapierre V; Lantéri-Minet M; Micallef J
    Cephalalgia; 2015 Nov; 35(13):1172-80. PubMed ID: 25667299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacotherapy of headache with special reference to migraine].
    Beubler E
    Wien Med Wochenschr; 1994; 144(5-6):100-1. PubMed ID: 8053212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A migraine prophylaxis educational intervention in a Medicaid population.
    Owens C; Pugmire B; Owens K
    Headache; 2008 Feb; 48(2):267-71. PubMed ID: 18194289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Spanish study of quality of life in migraine (II). Profile of medication consumption and subjective efficacy].
    Pascual J; Leira R; Láinez JM; Alberca R; Titus F; Morales F; Díez-Tejedor E; García de Polavieja J
    Neurologia; 1999 May; 14(5):204-9. PubMed ID: 10377720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triptan persistency among newly initiated users in a pharmacy claims database.
    Katić BJ; Rajagopalan S; Ho TW; Chen YT; Hu XH
    Cephalalgia; 2011 Mar; 31(4):488-500. PubMed ID: 20937605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Migraine: prophylactic treatment.
    Shukla R; Sinh M
    J Assoc Physicians India; 2010 Apr; 58 Suppl():26-9. PubMed ID: 21049704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A review of the pharmacologic treatment of migraine in children].
    Vasconcellos E
    Rev Neurol; 2003 Aug 1-15; 37(3):253-9. PubMed ID: 12938057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similarities and differences between chronic migraine and episodic migraine.
    Ferrari A; Leone S; Vergoni AV; Bertolini A; Sances G; Coccia CP; Ottani A; Pinetti D; Sternieri E
    Headache; 2007 Jan; 47(1):65-72. PubMed ID: 17355496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features and pharmacological treatment of migraine patients referred to headache specialists in Canada.
    Jelinski SE; Becker WJ; Christie SN; Giammarco R; Mackie GF; Gawel MJ; Eloff AG; Magnusson JE
    Cephalalgia; 2006 May; 26(5):578-88. PubMed ID: 16674767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents.
    van Leeuwen R; Tomany SC; Wang JJ; Klein R; Mitchell P; Hofman A; Klein BE; Vingerling JR; Cumming RG; de Jong PT
    Ophthalmology; 2004 Jun; 111(6):1169-75. PubMed ID: 15177967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zonisamide for migraine prophylaxis in refractory patients.
    Ashkenazi A; Benlifer A; Korenblit J; Silberstein SD
    Cephalalgia; 2006 Oct; 26(10):1199-202. PubMed ID: 16961786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy.
    Corrao G; Zambon A; Parodi A; Poluzzi E; Baldi I; Merlino L; Cesana G; Mancia G
    J Hypertens; 2008 Apr; 26(4):819-24. PubMed ID: 18327094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction in the intensity of abortive migraine drug use during coumarin therapy.
    Rahimtoola H; Egberts AC; Buurma H; Tijssen CC; Leufkens HG
    Headache; 2001 Sep; 41(8):768-73. PubMed ID: 11576200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Patterns of prescription and usage of triptans in Alsace (France): misuse is frequent and avoidable].
    Perearnau P; Vuillemet F; Schick J; Weill G
    Rev Neurol (Paris); 2006 Mar; 162(3):347-57. PubMed ID: 16585890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.